Answers are grounded in this paper and cite their sources.
A 59-year-old man with longstanding right-ear hearing loss presented with sudden left-ear hearing deterioration in October 2022 and had further acute presentations in January 2024 and March 2026. Each episode was clinically diagnosed as sudden hearing deterioration and treated as suspected SSNHL with systemic corticosteroids followed by local corticosteroid injections. Serial audiometry showed residual bilateral impairment. Two later left-ear speech-recognition percentages (65% and 40%) were recorded with contralateral masking, but their comparability could not be verified. Caloric and positional tests were normal or negative. Earlier temporal-bone CT reports described left chronic otomastoiditis, whereas the 2026 CT showed no middle-ear or mastoid soft-tissue opacification. No recent audiogram preceded the third attack, preventing retrospective confirmation of the acute threshold change. Incomplete speech-test details also limited comparison of the two scores. This case illustrates the importance of documenting stable hearing baselines, middle-ear status, and standardized speech outcomes when evaluating recurrent sudden hearing deterioration.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: